Listed SME IPO MAHALIFE

Mahamaya Lifesciences IPO GMP & Allotment

Mahamaya Lifesciences is a SME IPO with a price band of Rs 108.00 to Rs 114.00 that listed on 18 Nov 2025 at a listing gain of +1.75%. Track its full GMP history, subscription data and listing details here.

IPO Price Band
₹108.00 - ₹114.00
Lot Size
TBA
Bidding Closes
TBA
Listing Date
18 Nov 2025
Quick Answer & Highlights

Mahamaya Lifesciences IPO GMP Today & Key Takeaways

Last updated: 29 Dec 2025

Mahamaya Lifesciences IPO officially listed on 18 Nov 2025 at Rs 116.00, delivering a +1.75% listing gain compared to its issue price of Rs 114.00. Pre-listing, its final recorded Grey Market Premium (GMP) was ₹2.

Key Metric Figure Status / Context
Current GMP ₹2 +1.75% vs upper band (29 Dec 2025)
Est. Listing Price ₹116.00 +1.75% Est. Listing Gain
Price Band ₹108.00 - ₹114.00 SME IPO
Retail Minimum Investment TBA 1 Lot (TBA)
Bidding Window 11 Nov 2025 – TBA Listed
Allotment & Listing Dates Allotment: TBA Listing: 18 Nov 2025
Will you apply for this IPO?
Is this GMP accurate?
IPO Details

Complete IPO information

Mahamaya Lifesciences IPO Details and Specifications
IPO Open Date 11 Nov 2025
IPO Close Date TBA
IPO Price Band ₹108.00 - ₹114.00
Lot Size TBA
Current GMP ₹2
Estimated Listing Gain +1.75%
Issue Size -
Fresh Issue -
Issue Type SME
IPO Listing NSE, BSE
Retail Quota TBA
Registrar TBA
Overall Subscription TBA
Minimum Investment TBA
DRHP Draft Prospectus PDF
RHP Draft Prospectus -
Analysis

IPO Snapshot & Investor Takeaways

The latest recorded Grey Market Premium for Mahamaya Lifesciences stands at ₹2, implying an estimated listing gain of around 1.75% over the issue price if it holds until listing. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.

SME IPOs list on the dedicated SME platform of BSE/NSE. They usually involve smaller issue sizes and a higher per-lot investment than Mainboard issues, with comparatively lower institutional participation.

Timeline

IPO roadmap at a glance

✓
Bidding Opens 11 Nov 2025
✓
Bidding Closes TBA
✓
Allotment TBA
✓
Listing 18 Nov 2025
Mahamaya Lifesciences IPO Timeline and Important Dates Schedule
Event / Milestone Scheduled Date Status
Bidding Opens 11 Nov 2025 Completed
Bidding Closes TBA Completed
Allotment TBA Completed
Listing 18 Nov 2025 Completed
Market Lot

Application size breakdown

Mahamaya Lifesciences IPO Market Lot & Application Breakdown
Category Lots Shares Amount
Retail Minimum 1 Lot - -
Retail Maximum - - -
S-HNI Minimum - - -
S-HNI Maximum - - -
B-HNI Minimum - - -
Swipe to see more →
Fund Utilization

Objects of the Issue & Official Documents

Issue Notes

Important takeaways before applying

Additional note

Listed at 116.0 for 1.75% gains

Analysis

Mahamaya Lifesciences IPO Dates

Particular Dates
IPO Open Date 11 Nov 2025
IPO Close Date -
Basis of Allotment -
Refunds -
Credit to Demat Account -
IPO Listing Date 18 Nov 2025

Note: The timeline for Mahamaya Lifesciences IPO is tentative and subject to change.

Analysis

Mahamaya Lifesciences Objects of the Issue & Utilisation of Proceeds

To Be Updated Soon

Analysis

Mahamaya Lifesciences Company Financials

To Be Updated Soon

Analysis

Mahamaya Lifesciences Company Valuation – FY2026

To Be Updated Soon

Analysis

Mahamaya Lifesciences IPO Peer Group Comparison

To Be Updated Soon

Comparison

Compare Mahamaya Lifesciences IPO with similar IPOs

FAQ

Mahamaya Lifesciences IPO FAQs

Mahamaya Lifesciences IPO GMP today is Rs 2. Investors can use this GMP along with price band and subscription status for a better IPO review.
Based on the latest Grey Market Premium (GMP) of Rs 2 and an issue price of Rs 114, the estimated listing price for Mahamaya Lifesciences IPO is Rs 116.00 (approx 1.75% listing gain). Actual listing price is determined by market demand on the listing day.
Mahamaya Lifesciences IPO price band is Rs 108.00 to Rs 114.00. Check the latest issue price, lot size and GMP together before applying.
Mahamaya Lifesciences IPO open date is 11 Nov 2025, close date is TBA, and listing date is 18 Nov 2025.
Mahamaya Lifesciences IPO lot size is TBA. The minimum retail investment is TBA.
Mahamaya Lifesciences is classified as a SME IPO. This helps investors quickly understand the issue category and exchange segment.
Mahamaya Lifesciences IPO subscription status currently shows Subscription data is currently awaited.
In our empirical study of 117 Indian IPO listings, positive GMP was followed by a positive listing gain 69.8% of the time. However, as an exact forecast, the median variation between GMP-implied gain and actual listing price was 8 percentage points. GMP reflects informal market sentiment and should always be evaluated alongside company valuation and fundamentals.
Community discussion

Comments

Share a useful question or insight about Mahamaya Lifesciences.

Loading comments...

Leave a comment

Your email address will not be published. All comments and replies are reviewed before appearing.

Keep Exploring

Similar Recent IPOs

Related Topics
Mahamaya Lifesciences IPOMahamaya Lifesciences GMPMahamaya Lifesciences IPO GMPMahamaya Lifesciences IPO GMP todayMahamaya Lifesciences grey market premiumMahamaya Lifesciences price bandMahamaya Lifesciences subscription statusMahamaya Lifesciences allotment statusMahamaya Lifesciences listing dateMahamaya Lifesciences lot sizeMahamaya Lifesciences IPO reviewMahamaya Lifesciences IPO listing gain estimateMahamaya Lifesciences GMP calculatorMahamaya Lifesciences IPO 2025